Clinical Trial Update: Immunity Against AAV in Crigler Najjar Patient

View source ↗

Summary

A Genethon-sponsored trial update reports on immune responses to an AAV vector in a Crigler-Najjar syndrome patient. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crigler-najjar Syndrome

Snippet

Sponsor: Genethon | Conditions: Crigler Najjar Syndrome | Status: COMPLETED